Osaic Holdings’s Aptose Biosciences, Inc. APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14
Closed -$95 7854
2024
Q4
$95 Hold
14
﹤0.01% 7250
2024
Q3
$173 Hold
14
﹤0.01% 7196
2024
Q2
$319 Hold
14
﹤0.01% 7091
2024
Q1
$697 Hold
14
﹤0.01% 6759
2023
Q4
$1.07K Hold
14
﹤0.01% 6731
2023
Q3
$1.18K Hold
14
﹤0.01% 6783
2023
Q2
$1.95K Hold
14
﹤0.01% 6672
2023
Q1
$4.04K Hold
14
﹤0.01% 6433
2022
Q4
$4K Buy
14
+6
+75% +$1.61K ﹤0.01% 6455
2022
Q3
$2K Hold
8
﹤0.01% 6894
2022
Q2
$3K Sell
8
-1
-11% -$478 ﹤0.01% 6804
2022
Q1
$5K Hold
9
﹤0.01% 6542
2021
Q4
$5K Buy
9
+2
+29% +$1.88K ﹤0.01% 6687
2021
Q3
$7K Sell
7
-1
-13% -$1.25K ﹤0.01% 6417
2021
Q2
$11K Hold
8
﹤0.01% 6033
2021
Q1
$21K Buy
8
+7
+700% +$13.9K ﹤0.01% 5453
2020
Q4
$2K Sell
1
-8
-89% -$18.8K ﹤0.01% 6131
2020
Q3
$24K Sell
9
-84
-90% -$209K ﹤0.01% 4828
2020
Q2
$264K Sell
93
-83
-47% -$268K ﹤0.01% 2890
2020
Q1
$471K Buy
+176
New +$525K ﹤0.01% 2154

Other funds holding APTO

Osaic Holdings's APTO Position: Q1 2025 in Review

Osaic Holdings sold out of Aptose Biosciences, Inc. (APTO) in Q1 2025, closing a stake of 14 shares — an estimated $95 sold.

Osaic Holdings first reported a position in APTO in Q1 2020 and held it in 20 quarters. The position peaked at $471K in Q1 2020. 16 funds tracked by Wall St. Rank hold APTO as of Q1 2025.

  • Osaic Holdings reported no remaining Aptose Biosciences, Inc. position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 14 Aptose Biosciences, Inc. shares in Q1 2025, an estimated $95.
  • Osaic Holdings first reported a position in Aptose Biosciences, Inc. in Q1 2020 and held it in 20 quarters.
  • Osaic Holdings's Aptose Biosciences, Inc. position peaked at $471K in Q1 2020.
  • 16 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.